Nektar Therapeutics (NASDAQ:NKTR)
| 0.5059 Delayed Data As of Dec 08 |  -0.0014 / -0.28%Today’s Change | 0.41 Today|||52-Week Range 3.19 | -77.62% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Robin Howard W President & Chief Executive Officer |  Sale | 2/16/2023 | 19,635 | $3.00 | $58.9K | -83.02% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 2/16/2023 | 10,484 | $3.00 | $31.5K | -83.02% |
Thomsen Jillian B Chief Financial Officer | Sale | 2/16/2023 | 10,267 | $3.00 | $30.8K | -83.02% |
Wilson Mark A /nextkar/ Chief Legal Officer | Sale | 2/16/2023 | 8,275 | $3.00 | $24.8K | -83.02% |
Whitfield Roy A Director | Sale | 6/14/2023 | 30,000 | $0.57 | $17.1K | -8.13% |
Robin Howard W President & Chief Executive Officer | Sale | 5/16/2023 | 20,361 | $0.72 | $14.7K | -29.23% |
Robin Howard W President & Chief Executive Officer | Sale | 11/17/2023 | 19,877 | $0.49 | $9.7K | +5.09% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 5/16/2023 | 9,791 | $0.72 | $7.0K | -29.23% |
Wilson Mark A /nextkar/ Chief Legal Officer | Sale | 5/16/2023 | 7,543 | $0.72 | $5.4K | -29.23% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 11/17/2023 | 9,646 | $0.49 | $4.7K | +5.09% |
Page of 2